NCT05144152 Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)
| NCT ID | NCT05144152 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Colorectal Adenoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2021-12-13 |
| Primary Completion | 2024-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2021-12-13 with a primary completion date of 2024-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aim to evaluate the diagnostic accuracy of FIT and the novel panel of four bacterial gene markers collectively named as M3, to detect recurrent advanced adenomas in patients with history of colonic adenomas.
Eligibility Criteria
Inclusion Criteria: 1. Known colorectal adenomas during index colonoscopy; 2. Available baseline M3 and FIT results before index colonoscopy; 3. Aged ≥18 years old; 4. Written informed consent obtained. Exclusion Criteria: 1. Refusal or unfit to undergo surveillance colonoscopy; 2. Incomplete colonoscopy, incomplete removal of colorectal adenomas, or inadequate bowel preparation (defined as Boston Bowel Preparation Scale score 0 or 1 in any colonic segment) at index colonoscopy; 3. Previous colonic resection; 4. Personal history of colorectal cancer; 5. Personal history of polyposis syndrome; 6. Personal history of inflammatory bowel disease; 7. Known pregnancy or lactation; 8. Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above);
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05144152 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Adenoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05144152 currently recruiting?
Yes, NCT05144152 is actively recruiting participants. Contact the research team at mindai@link.cuhk.edu.hk for enrollment information.
Where is the NCT05144152 trial being conducted?
This trial is being conducted at Shatin, Hong Kong.
Who is sponsoring the NCT05144152 clinical trial?
NCT05144152 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 600 participants.